Low-intensity pulsed ultrasound as a strategy to boost exosome secretion by adipose-derived stem cells and uptake for myocardial infarction therapy
Biomedical Materials · 01.07.2025 · 20 (4) · 045025
DOI: 10.1088/1748-605x/ade925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 09.07.2025. Verfasst von Riyue Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029 Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Exosomes, Myocardial Infarction, Ultrasonic Waves, Adipose Tissue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Renmin Hospital of Wuhan University.
Abstract (Originalsprache)
Acute myocardial infarction (MI) remains a major global health issue, with limited therapeutic strategies to repair damaged myocardial tissue and improve long-term cardiac function. Exosome-based therapies, particularly those derived from adipose-derived stem cells (ADSCs), have shown significant promise in promoting cardiac repair. However, the low yield of exosomes from ADSCs has limited their clinical application. In this study, we investigate the potential of low-intensity pulsed ultrasound (LIPUS) to enhance exosome release from ADSCs and promote myocardial recovery. Our results demonstrate that LIPUS at 0.8 W cm −2 for 10 min effectively increases ADSC-derived exosome production by approximately 50% through inhibiting autophagy. Additionally, LIPUS treatment promotes the uptake of exosomes by hypoxic myocardial cells, further enhancing the therapeutic potential of ADSC-exosomes in MI. In vivo , the combination of LIPUS and exosomes significantly improved cardiac function, reduced inflammation, and attenuated myocardial apoptosis and fibrosis in a rat model of MI. These findings suggest that LIPUS can serve as a non-invasive strategy to boost exosome secretion and uptake, offering a promising approach for MI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029 Jiangsu, People's Republic of China.
- Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan 430060 Hubei, People's Republic of China.
- Department of Ultrasound Imaging, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000 Guangdong, People's Republic of China.
- Department of Ultrasound Imaging, Huangshi Central Hospital, Huangshi 435000 Hubei, People's Republic of China.
ORCID-Profile: Qing Zhou
Förderung
- National Natural Science Foundation of China
- Renmin Hospital of Wuhan University
Zitieren
APA
Jiang, R., Wang, H., Zhong, F., Hu, Y., Liu, J., Chen, Y., Su, W., Cao, S., Deng, Q., & Zhou, Q. (2025). Low-intensity pulsed ultrasound as a strategy to boost exosome secretion by adipose-derived stem cells and uptake for myocardial infarction therapy. Biomedical Materials, 20(4), 045025. https://doi.org/10.1088/1748-605x/ade925
Vancouver
Jiang R, Wang H, Zhong F, Hu Y, Liu J, Chen Y, et al. Low-intensity pulsed ultrasound as a strategy to boost exosome secretion by adipose-derived stem cells and uptake for myocardial infarction therapy. Biomedical Materials. 2025;20(4):045025. doi:10.1088/1748-605x/ade925
BibTeX
@article{Jiang2025,
author = {Jiang, Riyue and Wang, Hao and Zhong, Fanglu and Hu, Yugang and Liu, Junbi and Chen, Yueying and Su, Wendi and Cao, Sheng and Deng, Qing and Zhou, Qing},
title = {Low-intensity pulsed ultrasound as a strategy to boost exosome secretion by adipose-derived stem cells and uptake for myocardial infarction therapy},
journal = {Biomedical Materials},
year = {2025},
volume = {20},
number = {4},
pages = {045025},
doi = {10.1088/1748-605x/ade925}
}
EUVIMED